全文获取类型
收费全文 | 4507篇 |
免费 | 338篇 |
国内免费 | 347篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 95篇 |
妇产科学 | 53篇 |
基础医学 | 537篇 |
口腔科学 | 93篇 |
临床医学 | 594篇 |
内科学 | 754篇 |
皮肤病学 | 57篇 |
神经病学 | 216篇 |
特种医学 | 486篇 |
外国民族医学 | 2篇 |
外科学 | 364篇 |
综合类 | 511篇 |
一般理论 | 1篇 |
预防医学 | 285篇 |
眼科学 | 106篇 |
药学 | 451篇 |
3篇 | |
中国医学 | 179篇 |
肿瘤学 | 389篇 |
出版年
2024年 | 9篇 |
2023年 | 34篇 |
2022年 | 118篇 |
2021年 | 160篇 |
2020年 | 97篇 |
2019年 | 116篇 |
2018年 | 141篇 |
2017年 | 101篇 |
2016年 | 97篇 |
2015年 | 151篇 |
2014年 | 177篇 |
2013年 | 204篇 |
2012年 | 234篇 |
2011年 | 281篇 |
2010年 | 203篇 |
2009年 | 205篇 |
2008年 | 168篇 |
2007年 | 232篇 |
2006年 | 226篇 |
2005年 | 251篇 |
2004年 | 131篇 |
2003年 | 160篇 |
2002年 | 113篇 |
2001年 | 110篇 |
2000年 | 103篇 |
1999年 | 104篇 |
1998年 | 153篇 |
1997年 | 147篇 |
1996年 | 147篇 |
1995年 | 103篇 |
1994年 | 85篇 |
1993年 | 76篇 |
1992年 | 30篇 |
1991年 | 34篇 |
1990年 | 35篇 |
1989年 | 58篇 |
1988年 | 56篇 |
1987年 | 58篇 |
1986年 | 36篇 |
1985年 | 46篇 |
1984年 | 26篇 |
1983年 | 18篇 |
1982年 | 27篇 |
1981年 | 20篇 |
1980年 | 30篇 |
1979年 | 9篇 |
1978年 | 11篇 |
1977年 | 16篇 |
1976年 | 26篇 |
1975年 | 15篇 |
排序方式: 共有5192条查询结果,搜索用时 15 毫秒
71.
72.
目的总结胸腺扩大切除术治疗重症肌无力(myasthenia gravis,MG)的外科治疗经验,探讨MG外科治疗效果。方法回顾性分析我院1996年6月至2017年10月期间527例行胸腺扩大切除术的MG患者临床病例资料,其中男242例,女285例;年龄5~77岁,平均(52.6±13.7)岁。病程12天~18年。合并甲状腺功能亢进症22例,纯红细胞再生障碍性贫血7例,甲状腺机能减退症、肠激惹症、风湿性关节炎、强直性脊柱炎和血小板减少综合征各1例。改良OssermanⅠ型272例,Ⅱa型72例,Ⅱb型78例,Ⅲ型81例,Ⅳ型24例。所有患者肌疲劳试验、新斯的明试验阳性,胸部CT检查明确诊断。总结围手术期相关资料及术后随访情况。结果围手术期死亡3例,均为胸腺瘤合并MG,其中OssermanⅢ型MG 2例、Ⅳ型MG 1例。术后肌无力危象15例,其中OssermanⅡb型2例、Ⅲ型11例、Ⅳ型2例,气管切开7例。血浆置换70例,并发低渗综合征、下肢静脉血栓各2例。术后病理诊断胸腺增生293例(55.60%)、胸腺瘤207例(39.28%)、胸腺囊肿24例(4.55%)和胸腺萎缩3例(0.57%)。随访378例,平均随访(85.9±58.5)月;MG完全缓解、部分缓解、无变化和恶化患者分别为135例(35.71%)、192例(50.79%)、41例(10.85%)和10例(2.65%)。完全缓解率OssermanⅠ>Ⅱa>Ⅳ>Ⅱb>Ⅲ型,恶化率OssermanⅢ>Ⅳ>Ⅰ型。OssermanⅠ型外科治疗无效18例,术前病程>5~10年;恶化1例,为应用电视胸腔镜胸腺切除的眼肌型MG患者,遗留胸腺左叶未切除,6年后发展为重度全身型,再次手术切除遗留的左叶胸腺,证实左叶胸腺代偿性肥大增生。恶化患者中死亡6例,均为胸腺瘤合并MG,其中OssermanⅢ型5例、Ⅳ型1例;死亡原因为肌无力危象3例,快速停服溴吡斯的明3个月后突发呼吸骤停猝死2例,胆碱能危象1例。结论规范的胸腺扩大切除是治疗MG的有效方法,眼肌型MG尽早手术可有效降低其全身性转化风险。OssermanⅡb型以上MG易发生肌无力危象,围手术期采取综合处理措施有助于降低MG相关风险。重症术后远期可反复发生肌无力危象,须规律用药,并采取MG综合治疗措施。 相似文献
73.
Sui An Lie Sook Wai Wong Loong Tat Wong Theodore Gar Ling Wong Shin Yuet Chong 《Journal canadien d'anesthésie》2020,67(7):885-892
Coronavirus disease (COVID-19) was declared a pandemic by the World Health Organization on 11 March 2020 because of its rapid worldwide spread. In the operating room, as part of hospital outbreak response measures, anesthesiologists are required to have heightened precautions and tailor anesthetic practices to individual patients. In particular, by minimizing the many aerosol-generating procedures performed during general anesthesia, anesthesiologists can reduce exposure to patients’ respiratory secretions and the risk of perioperative viral transmission to healthcare workers and other patients. To avoid any airway manipulation, regional anesthesia should be considered whenever surgery is planned for a suspect or confirmed COVID-19 patient or any patient who poses an infection risk. Regional anesthesia has benefits of preservation of respiratory function, avoidance of aerosolization and hence viral transmission. This article explores the practical considerations and recommended measures for performing regional anesthesia in this group of patients, focusing on control measures geared towards ensuring patient and staff safety, equipment protection, and infection prevention. By doing so, we hope to address an issue that may have downstream implications in the way we practice infection control in anesthesia, with particular relevance to this new era of emerging infectious diseases and novel pathogens. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not the first, and certainly will not be the last novel virus that will lead to worldwide outbreaks. Having a well thought out regional anesthesia plan to manage these patients in this new normal will ensure the best possible outcome for both the patient and the perioperative management team. 相似文献
74.
中医证素辨证研究概况 总被引:5,自引:0,他引:5
朱文锋教授经过32年的深入研究,创立了"证素辨证"新体系。随着证素辨证这一新型辨证方法的提出,关于证素的相关研究就迅速成为中医学基础与临床研究的一大热点。证素辨证具有良好的临床和科研的兼容性、坚实的理论基础和日益丰富的应用经验,其未来前景不可限量。 相似文献
75.
C/EBP is a sequence-specific DNA-binding protein.In order to identify its distribu-tion,localization and function,immunocytochemical technique(ABC method)was done usinganti-C/EBP polypeptide antibodies 1103~#,425~# in liver specimens from 20 normal adult,5neonatal,6 patients with hepatitis,25 patients with liver cirrhosis,80 patients with hepatocellu-lar carcinoma(40 cases were associated with surrounding nontumorous tissues)and 26 patientswith cholangiocarcinoma(15 cases were associated with surrounding nontumorous tissues).Theresults showed that C/EBP was diffusely distributed in nuclei and cytoplasm of differentiated liv-er cells and very low or undetectable in liver cancer cells.The expression of C/EBP was in pro-portion to differentiated degree of tumor cells,and was obviously weaker than that in surround-ing nontumorous tissues.C/EBP positive staining has also been found in regenerating epithelialcells of bile ductules.The results suggested that C/EBP might play an important role in estab-lishing and maintaining the differentiation of liver cells and might exert an inhibiting effect againsttransformation of liver cells and proliferation of neoplastic tissue. 相似文献
76.
77.
78.
Menthol, the cooling natural product of peppermint, is widely used in medicinal preparations for the relief of acute and inflammatory pain in sports injuries, arthritis, and other painful conditions. Menthol induces the sensation of cooling by activating TRPM8, an ion channel in cold-sensitive peripheral sensory neurons. Recent studies identified additional targets of menthol, including the irritant receptor, TRPA1, voltage-gated ion channels and neurotransmitter receptors. It remains unclear which of these targets contribute to menthol-induced analgesia, or to the irritating side effects associated with menthol therapy. Here, we use genetic and pharmacological approaches in mice to probe the role of TRPM8 in analgesia induced by L-menthol, the predominant analgesic menthol isomer in medicinal preparations. L-menthol effectively diminished pain behavior elicited by chemical stimuli (capsaicin, acrolein, acetic acid), noxious heat, and inflammation (complete Freund’s adjuvant). Genetic deletion of TRPM8 completely abolished analgesia by L-menthol in all these models, although other analgesics (acetaminophen) remained effective. Loss of L-menthol–induced analgesia was recapitulated in mice treated with a selective TRPM8 inhibitor, AMG2850. Selective activation of TRPM8 with WS-12, a menthol derivative that we characterized as a specific TRPM8 agonist in cultured sensory neurons and in vivo, also induced TRPM8-dependent analgesia of acute and inflammatory pain. L-menthol– and WS-12–induced analgesia was blocked by naloxone, suggesting activation of endogenous opioid-dependent analgesic pathways. Our data show that TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. In contrast to menthol, selective TRPM8 agonists may produce analgesia more effectively, with diminished side effects. 相似文献
79.
80.
为探讨牙周病发病的危险因素 ,作者在武汉市机关干部体检中对 193对牙周病患者进行 1∶ 1配比的病例对照研究。结果表明 ,牙结石、吸烟、饮酒是牙周病的危险因素 ,其 OR值分别为5.31、2 .13和 1.86;未发现饮茶与牙周病的发病有统计学联系。吸烟与牙结石在牙周病致病过程中呈协同作用 ,OR值高达 18.92。牙周病归因于饮酒、吸烟及牙结石的暴露人群归因危险百分比分别为 4 6.2 4 %、53.31%及 81.17% ,总体人群归因危险百分比分别为 2 5.12 %、2 4 .0 4 %及 4 6.2 9%。 相似文献